)
)
)
Roundtable: USA - How Recent PTAB Policy Shifts Are Reshaping IPR, PGR and Global Dispute Strategies
Recent policy changes at the U.S. Patent Trial and Appeal Board (PTAB) have reduced the weighting given to discretionary denials and recalibrated the role of both inter partes review (IPR) and post-grant review (PGR) proceedings. This session examines evolving PTAB standards and practices, addressing how life science and technology companies can adapt their invalidity approaches in response and how modern PTAB activity interacts with parallel proceedings and the broader global litigation landscape.
